Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical presentation and outcomes of pituitary apoplexy in patients with PitNETs: a real world Italian multicenter study.

Journal of endocrinological investigation·2025

Same author

Bone status in patients with chronic hypoparathyroidism: results from the Italian HypoparaNET database.

Aging clinical and experimental research·2025

Same author

Intricate diagnosis due to falsely elevated testosterone levels by immunoassay.

Endocrine·2025

Same author

Financial Toxicity and Kidney Disease in Children and Adults: A Scoping Review.

International journal of nephrology and renovascular disease·2025

Same author

Parathyroid carcinoma and atypical parathyroid tumor: analysis of an Italian database.

European journal of endocrinology·2024

Same author

Financial Toxicity in Renal Patients (FINTORE) Study: A Cross-Sectional Italian Study on Financial Burden in Kidney Disease-A Project Protocol.

Methods and protocols·2024

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Thyroid papillary microcarcinoma: a descriptive and meta-analysis study.

Elio Roti¹, Ettore C degli Uberti, Marta Bondanelli

¹Institute of Endocrinology, University of Milan, 20133 Milan, Italy. elio.roti@unimi.it

European Journal of Endocrinology

|August 21, 2008

Summary

This review covers thyroid microcarcinoma, detailing its anatomy, prevalence, and diagnostic methods. It analyzes risk factors for aggressiveness and summarizes current treatment guidelines for this condition.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Related Experiment Videos

Last Updated: Jul 2, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Area of Science:

Endocrinology
Oncology
Pathology

Background:

Thyroid microcarcinoma, defined as a small thyroid cancer, presents unique diagnostic and management challenges.
Understanding its anatomical and clinical characteristics is crucial for effective patient care.

Purpose of the Study:

To provide a comprehensive review of thyroid microcarcinoma, encompassing its epidemiology, diagnostics, and risk factors.
To analyze clinical, pathological, and therapeutic factors associated with cancer aggressiveness using meta-analysis.
To report on various treatment modalities and current society guidelines.

Main Methods:

Systematic literature review of anatomical, clinical, and prevalence data.
Meta-analysis of clinical, pathological, and therapeutic risk factors for aggressiveness.
Compilation of reported treatment procedures and established clinical guidelines.

Main Results:

The review synthesizes current knowledge on thyroid microcarcinoma's characteristics and prevalence.
Meta-analysis identifies key risk factors influencing cancer aggressiveness at diagnosis and during follow-up.
Diverse treatment approaches and expert-recommended guidelines are presented.

Conclusions:

Thyroid microcarcinoma requires careful evaluation of anatomical and clinical features.
Identifying prognostic factors is essential for tailoring treatment and follow-up strategies.
Adherence to established guidelines ensures optimal management of thyroid microcarcinoma.